Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

THR-149 for the Treatment of DME: Results of a Phase 1, Open Label, Dose Escalation Study

Dr. Pravin Dugel: "THR-149 for the Treatment of DME: Results of a Phase 1, Open Label, Dose Escalation Study". Paris, 8 September 2019.

Publication date: 
September, 2019
Attachment: 
PDF icon THR-149-001_Euretina_ DrDugel_8SEPT.pdf